Analytical Data
-
Gene name
SYAP1
- Application
-
Alternative Names
FLJ14495; FLJ44185; PRO3113; SAP47 homolog; Syap1; SYAP1_HUMAN; Synapse associated protein 1; Synapse associated protein 1 SAP47 homolog (Drosophila); Synapse-associated protein 1
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q96A49
-
Expression Region
1-352 aa
-
AA Sequence
MFRGLSSWLG LQQPVAGGGQ PNGDAPPEQP SETVAESAEE ELQQAGDQEL LHQAKDFGNY LFNFASAATK KITESVAETA QTIKKSVEEG KIDGIIDKTI IGDFQKEQKK FVEEQHTKKS EAAVPPWVDT NDEETIQQQI LALSADKRNF LRDPPAGVQF NFDFDQMYPV ALVMLQEDEL LSKMRFALVP KLVKEEVFWR NYFYRVSLIK QSAQLTALAA QQQAAGKEEK SNGREQDLPL AEAVRPKTPP VVIKSQLKTQ EDEEEISTSP GVSEFVSDAF DACNLNQEDL RKEMEQLVLD KKQEETAVLE EDSADWEKEL QQELQEYEVV TESEKRDENW DKEIEKMLQE EN
-
Molecular Weight
39.9 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SYAP1 (syndromic autism protein 1) has garnered significant attention in recent years due to its potential role in neurodevelopmental disorders, particularly autism spectrum disorders (ASD). Research indicates that SYAP1 is involved in synaptic development and plasticity, processes crucial for proper neuronal function and communication. Dysregulation of SYAP1 has been associated with various syndromes characterized by cognitive and behavioral impairments, making it a compelling target for therapeutic exploration. The study of SYAP1 recombinant protein aims to elucidate its structural and functional properties, which could provide insights into its mechanisms of action in the brain. Additionally, understanding the interactions of SYAP1 with other synaptic proteins can shed light on the molecular underpinnings of ASD and related disorders. By generating and characterizing SYAP1 recombinant proteins, researchers seek to identify potential biomarkers for early diagnosis and to develop targeted interventions that could mitigate the effects of SYAP1-related dysregulation. Overall, the investigation of SYAP1 as a recombinant protein represents a promising avenue for advancing our understanding of complex neurodevelopmental conditions and improving therapeutic strategies.
